等待开盘 09-18 09:30:00 美东时间
-0.750
-1.65%
BTIG initiates coverage on Bright Minds Biosciences with a Buy rating, citing BMB‑101's potential and key Phase 2 data expected by the end of 2025
09-09 01:54
BTIG analyst Thomas Shrader initiates coverage on Bright Minds Biosciences (NASDAQ:DRUG) with a Buy rating and announces Price Target of $72.
09-08 18:10
https://www.marijuanamoment.net/military-to-start-testing-service-members-for-the-psychedelic-psilocin-memo-shows/
08-29 02:16
First concentrated, ready-to-dilute liquid glucagon available for diagnostic procedures SHIRLEY, N.Y., Aug. 27, 2025 /PRNewswire/ -- American Regent, Inc.® is pleased to announce the commerc...
08-27 20:35
Bright Minds Biosciences, a biotech company focused on developing selective 5-HT2 agonists for CNS disorders, will present at four upcoming conferences: the 36th International Epilepsy Congress in Lisbon, the Cantor Global Healthcare Conference, the H.C. Wainwright Global Investment Conference, and the Baird Global Healthcare Conference. Webcasts are available for the Cantor event. The company aims to address unmet medical needs in epilepsy, depr...
08-25 12:00
DUBLIN, Aug. 20, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) will host an investor webcast on Wednesday, August 27, 2025, at 4:30 p.m. EDT / 9:30 p.m. IST to provide an over...
08-21 04:15
今日重点评级关注:Canaccord Genuity:维持Cipher Mining"买入"评级,目标价从8美元升至9美元;美银证券:维持小鹏汽车"买入"评级,目标价从25美元升至26美元
08-20 10:48
HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Bright Minds Biosciences (NASDAQ:DRUG) with a Buy and maintains $85 price target.
08-20 01:55
编者按:春秋淬炼,凤凰涅��——这正是过去五载中国大健康产业的真实写照。 产业发展的每一步,皆铭刻着领航者的智慧与抉择。值此第五届华夏大健康产业发展大会启幕之际,《华夏时报》大健康团队推出 “我们这五年”系列专题报道,回溯跌宕征程,聆听核心亲历者的破局之声。
07-30 16:50
https://www.foxnews.com/health/key-living-longer-could-tied-surprising-substance-study-suggests
07-16 22:45